PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract of S. racemosa bark showed significant dose-dependent restoration of serum enzymes, bilirubin, albumin, and total protein in CCl4-induced hepatic damage in rats [PMID:22022156].
Aqueous extracts significantly stimulated serum FSH and LH levels in immature female rats, enhancing folliculogenesis [PMID:15261983].
Bark extract exhibited significant anti-inflammatory and analgesic effects at 300 and 500mg/kg doses in mice and rats [PMID:26045374].
S. racemosa was found to be effective in experimental models of wound healing [PMID:15866825].
A polyherbal formulation (DXB-2030) containing S. racemosa reversed testosterone propionate-induced changes in female rats [PMID:30863446].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 26851499 (2016) — A comprehensive analysis on Symplocos racemosa Roxb.: Traditional uses, botany, phytochemistry and pharmacological activities. · Journal of ethnopharmacology
- 2.PMID: 25549060 (2014) — Flavonoids from Symplocos racemosa. · Molecules (Basel, Switzerland)
- 3.PMID: 40917526 (2025) — Phytocompounds of Honey mesquite (Prosopis glandulosa) and Lodhra (Symplocos racemosa) in the management of COVID-19 associated rheumatoid arthritis (CARA). · In silico pharmacology
- 4.PMID: 22022156 (2011) — Hepatoprotective activity of Symplocos racemosa bark on carbon tetrachloride-induced hepatic damage in rats. · Journal of Ayurveda and integrative medicine
- 5.PMID: 33203457 (2020)